Drug reimbursement: New CAP (competitive acquisition program) will roll out nationwide and allow you to acquire most Part B drugs without purchasing them

Article Overview

This article explains CMS’s nationwide rollout of the competitive acquisition program (CAP) for Medicare Part B drugs and the operational changes it introduces for physician practices and drug vendors. It covers enrollment timing, drug supply logistics, claims filing timeframes, vendor responsibilities, patient billing issues, subcontracting, excluded drug categories, and other implementation details that affect practices participating in the program. The content is aimed at providers, practice managers, and medical billing/coding professionals who need to understand how the new drug reimbursement model differs from standard Part B purchasing and billing processes.